Most U.S. device firms seek overseas regulatory approval first

10/7/2011 | MassDevice.com (Boston)

A Northwestern University report found that more than 75% of U.S. medical device firms turn to overseas markets first before filing for a 510(k) clearance, driven in part by unpredictability, high costs and long review times associated with the FDA process. The study, commissioned by the Institute for Health Technology Studies, was a counter response to an Institute of Medicine report that called for the elimination of the 510(k) process.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC